Bnb Plus (BNBX) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Bnb Plus Corp   (NASDAQ: BNBX)
    Sector • Technology    Industry • IT Infrastructure
   Industry • IT Infrastructure
   Sector • Technology

Select the Financial Report: Select the Period:


Description of Bnb Plus's Business Segments
The company operates primarily in the Therapeutic DNA Production Services segment and previously in the DNA Tagging Security Products segment. The Therapeutic DNA Production Services segment utilizes proprietary technologies and know-how protected by patents, trade secrets, and trademarks. As of December 15, 2025, the company's patent portfolio for this segment includes eight issued patents and eight pending patent applications in the United States, as well as twelve issued foreign patents and eight pending foreign patent applications. The company operates in a competitive market with various competitors. Customers in these segments are generally not obligated to make purchases and may terminate orders or contracts with minimal or no financial penalty, which presents risks to the company's revenue and business results.

Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Composition of Bnb Plus Corp Revenues by Segments
 
Product revenues    98.42 % of total Revenue
Research and development services Point in Time    0.23 % of total Revenue
Supply chain Point in Time    4.73 % of total Revenue
Large Scale DNA Production Point in Time    95.04 % of total Revenue
Service revenues    1.58 % of total Revenue
segment    100 % of total Revenue
Therapeutic DNA Production Services    62.34 % of total Revenue
Therapeutic DNA Production Services Product revenues    62.34 % of total Revenue
DNA Tagging and Security Products    37.66 % of total Revenue
DNA Tagging and Security Products Product revenues    36.08 % of total Revenue
DNA Tagging and Security Products Service revenues    1.58 % of total Revenue

Q2 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)		 %
(of total Revenues)
Product revenues 1.01 98.42 %
Research and development services Point in Time 0.00 0.23 %
Supply chain Point in Time 0.05 4.73 %
Large Scale DNA Production Point in Time 0.97 95.04 %
Service revenues 0.02 1.58 %
segment 1.02 100 %
Therapeutic DNA Production Services 0.64 62.34 %
Therapeutic DNA Production Services Product revenues 0.64 62.34 %
DNA Tagging and Security Products 0.39 37.66 %
DNA Tagging and Security Products Product revenues 0.37 36.08 %
DNA Tagging and Security Products Service revenues 0.02 1.58 %
Total 1.02 100 %




Q2 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%		 Q/Q Revenue
%
Product revenues 83.71 % 81.57 %
Research and development services Point in Time -98.23 % -
Supply chain Point in Time -83.31 % -
Large Scale DNA Production Point in Time 191.7 % -
Service revenues -92.43 % -
segment 4.14 % -
Therapeutic DNA Production Services 36.65 % -
Therapeutic DNA Production Services Product revenues 52.22 % -
DNA Tagging and Security Products 74.87 % -
DNA Tagging and Security Products Product revenues - -
DNA Tagging and Security Products Service revenues - -
Total - 81.13 %




Q2 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)		 %
(Profit Margin)
segment 0.83 80.73 %
Total -6.67 -




Q2 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%		 Q/Q Income
%
segment 122.95 % -
Total - -




Annual Report on Bnb Plus Corp Divisions, Sales by Country

 
Americas   Americas Segment contribution to total sales 54.97 % of total Revenue
Europe   Europe Segment contribution to total sales 5.74 % of total Revenue
Asia and other   Asia and other Segment contribution to total sales 55.5 % of total Revenue


Twelve months ended 2025
BNBX s Annual Revenue by Geography and Business Segments Sales
(in millions $)		 %
(of total Sales)
Total 1.84 100 %
Americas 1.01 54.97 %
Europe 0.11 5.74 %
Asia and other 1.02 55.5 %


Twelve months ended 2025
BNBX s Annual Income by Country and Business Segments Income
(in millions $)		 %
(Profit Margin)
Total -15.35 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Product revenues - -
Service revenues - -
segment - -
DNA Tagging and Security Products - -
DNA Tagging and Security Products Product revenues - -
DNA Tagging and Security Products Service revenues - -
Americas 6.19 % -
Europe -38.75 % -
Asia and other 3.17 % -
Therapeutic DNA Production - -
Therapeutic DNA Production Product revenues - -
Therapeutic DNA Production Service revenues - -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.